R. Nordsborg

First name

R.

Middle name

B.

Last name

Nordsborg

Davies, M., Alibegovic, A. C., Anil, G., Braae, U. C., Jensen, A. B., & Nordsborg, R. B. (2023). Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes. Diabet Med, e15267. http://doi.org/10.1111/dme.15267

View

Davies, M. J., Alibegovic, A. C., Jensen, A. B., Munikrishnappa, R., Nordsborg, R. B., & Braae, U. C. (2023). Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.15165

View

le Roux, C. W., Hartvig, N. V., Haase, C. L., Nordsborg, R. B., Olsen, A. H., & Satylganova, A. (2020). Obesity, cardiovascular risk and healthcare resource utilization in the UK. Eur J Prev Cardiol. http://doi.org/10.1177/2047487320925639

View

le Roux, C. W., Hartvig, N. V., Haase, C. L., Nordsborg, R. B., Olsen, A. H., & Satylganova, A. (2021). Obesity, cardiovascular risk and healthcare resource utilization in the UK. Eur J Prev Cardiol. http://doi.org/10.1177/2047487320925639

View

Khunti, K., Hertz, C. L., Husemoen, L. L. N., Mocevic, E., Nordsborg, R. B., Piltoft, J. S., & Bain, S. C. (2021). Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study. Diabet Med. http://doi.org/10.1111/dme.14697

View